Health In Tech Q1 revenue up 9% YoY to $8.8M; guides FY2026 revenue $45-50M; EBITDA turns negative on growth spend

Health In Tech, Inc.

Q1 2026 total revenue $8.8M (+9% YoY); adjusted EBITDA -$1.3M vs. +$1.2M in Q1 2025.
FY2026 revenue guidance $45M-$50M, implying ~35-50% YoY growth; company investing in sales and marketing.
Platform placed plan value $82.0M; contracted revenue $22.9M; broker/TPA count 896 (+29% YoY).
Fee-based model with no plan or underwriting risk; AI-enabled marketplace for self-funded health plans.
Q1 2026 net loss of $1.6M vs. net income of $0.5M in Q1 2025; stock-based comp and amortization were key adjustments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.